전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
the jurisdiction of tax residence of the surrogate parent entity has not notified the member state of a systemic failure;
il-ġurisdizzjoni tar-residenza tat-taxxa tal-entità prinċipali ta’ sostituzzjoni ma tkunx innotifikat l-istat membru b’nuqqas sistemiku;
persistent infection that lasts for at least 6 months has also been shown to be a relevant surrogate marker for cervical cancer.
infezzjoni persistenti li ddum għal mill-anqas 6 xhur intweriet li kienet ukoll markatur ta’ sostituzzjoni rilevanti għall-kanċer tal-għonq tal-utru.
the greek authorities prohibited lags awarding grants to lag staff or members,to surrogate natural orlegal entities ortospousesandfirst degree relatives.
ukollf’lagsżgħar, membru ta’ laggħandul-opportunitàjinfluwenzad-deċiżjonisaħansitra mingħajr ma jieħu sehem fil-votazzjoni.
in a 26 week toxicity study performed in mice with a surrogate antibody directed against murine c5, treatment did not affect any of the toxicity parameters examined.
fi studju ta '26 ġimgħa dwar it- tossiċità mwettaq fil- ġrieden b' antikorp sostitut dirett kontra c5 tal - ġrieden, il- kura ma affettwat ebda parametru tat- tossiċità eżaminat.
no clear treatment-related effects or adverse effects were observed in reproductive toxicology studies in mice with a surrogate terminal complement inhibitory antibody.
ma kienu osservati ebda effetti marbuta mal- kura jew effetti avversi fi studji tat- tossikoloġija riproduttiva fi ġrieden b' antikorp sostitut li jimpedixxi l- komplement terminali.
however, neither of these entities has been evidenced to be a general surrogate marker for efficacy (svr12) at the therapeutic 400 mg dose.
madankollu, l-ebda waħda minn dawn l-entitajiet ma ġiet evidenzjata li hi markatur surrogate ġenerali għall-effikaċja (svr12) fid-doża terapewtika ta’ 400 mg.
passports of any kind (national passports, diplomatic passports, service passports, collective passports and surrogate passports including children's passports);
passaporti ta' kull tip (passaporti nazzjonali, passaporti diplomatiċi, passaporti tas-servizz, passaporti kollettivi u passaporti alternattivi inklużi l-passaporti tat-tfal);
passports of any kind (national passports, diplomatic passports, service passports, collective passports and surrogate passports including children's passports),
passaporti ta' kull tip (passaporti nazzjonali, passaporti diplomatiċi, passaporti tas-servizz, passaporti kollettivi u passaporti sostituti li jinkludu l-passaporti tat-tfal),
anal intraepithelial neoplasia (ain) grade 2/3 (moderate to high-grade dysplasia) was used in the clinical trials as a surrogate marker for anal cancer.
neoplasja intraepiteljali anali (ain) ta’ grad 2/3 (displasja ta’ grad minn moderat sa għoli) intużat fil-provi kliniċi bħala markatur sostitut ta’ kanċer anali.